The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...

Dr. Marty Makary, FDA commissioner, joins 'Squawk Box' to discuss what hindsight tells science about the best route to take post-Covid, changes to the Vaccine Advisory Committee and much more.

Carlene Pavlos, executive director of the Massachusetts Public Health Association, one of the plaintiffs, said in a statement ...

The Food and Drug Administration Thursday granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

The convergence of multiple crises—including the COVID-19 pandemic, geopolitical fragmentation, climate shocks, digital disruption, and economic precarity—has exposed the fragility and limitations of ...

US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...

The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...

Pfizer's COVID vaccine (Comirnaty) is fully approved for patients ages 12 and up, and authorized for kids ages 6 months ...

Three deaths reported nationally as Ohio's outbreak ends with 35 cases, while Texas accounts for 753 infections in the ...

Photo: Adobe Stock Despite the CDC’s move to kick the COVID-19 vaccine off recommended immunization schedules for children ...